GEN Exclusives

More »
GEN Articles

Related to Tolerx and GSK Suspend Second Phase III Diabetes Trial as Defend-1 Otelixizumab Study Fails

  • Page 6 of 6 (107 items) First ... 6 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

U.S. Science Funding Elixirs

Are proposals to circumvent the usual mechanisms of federal funding realistic?